Document Detail


Immunohistochemical detection of mutant p53 protein in regional lymph nodes is associated with adverse outcome in stage II colorectal cancer.
MedLine Citation:
PMID:  10682269     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Epidemiologic data identifies a cohort of Duke's B (CRC) patients whose survival more closely matches that of Duke's C. Lymph node micrometastases may account for this discrepancy. Lymph node expression of mutant p53 protein (Mp53P) has been linked to a reduction in survival in Japanese Duke's B patients. We aimed to determine the significance of nodal p53 expression in European Duke's B patients using immunohistochemistry. The study comprised 134 consecutive patients who had resections for CRC between 1984 and 1991. End points were 5 year disease free survival or CRC related death. Thirty-four subjects did not achieve end points and were excluded. We examined tumour and nodal sections for Mp53P by immunohistochemistry and correlated this with survival using a Kaplan-Meier (KM) and a Cox Proportional hazards model (CPHT). Five year survival was 73%. Fifty-eight percent of primary tumours expressed Mp53P. Tumour p53 expression did modulate survival behavior. Twenty-six percent of subjects' lymph nodes expressed Mp53P. Fifty-three per cent of those with positive and 17% of those with negative lymph nodes died of recurrence. The relative risk for nodal Mp53P expression was 3.1. There was a significant univariate relationship between lymph node p53 expression and mortality. (Log Rank p = 0.028). Multivariate analysis also showed a significant relationship with mortality. (CPHT p = .03). We conclude that lymph node expression of Mp53P is associated with increased mortality in Duke's B CRC.
Authors:
G Clarke; E Ryan; J Crowe; J C O'Keane; P MacMathúna
Related Documents :
8244569 - Intratumoral microvessel density and p53 protein: correlation with metastasis in head-a...
23522769 - Carcinoma of the oral tongue: a case series analysis of prognostic factors and surgical...
17162129 - Expression of bax, p53, and p27/kip in patients with papillary thyroid carcinoma with o...
11304849 - Predictive value of topoisomerase ii alpha immunostaining in urothelial bladder carcinoma.
18559599 - Rhamm, p21 combined phenotype identifies microsatellite instability-high colorectal can...
10927139 - Cell proliferation and apoptosis in stage iii inoperable non-small cell lung carcinoma ...
15501959 - A phase i and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patie...
20380529 - The relevance of simpson grade i and ii resection in modern neurosurgical treatment of ...
2466129 - Retention and clearance of inhaled submicron carbon black particles.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of histochemistry : EJH     Volume:  43     ISSN:  1121-760X     ISO Abbreviation:  Eur J Histochem     Publication Date:  1999  
Date Detail:
Created Date:  2000-03-22     Completed Date:  2000-03-22     Revised Date:  2008-08-15    
Medline Journal Info:
Nlm Unique ID:  9207930     Medline TA:  Eur J Histochem     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  311-6     Citation Subset:  IM    
Affiliation:
Department of Gastroenterology, Mater Misericordiae Hospital, Dublin, Ireland. gclarke@rics.bwh.harvard.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Colorectal Neoplasms / chemistry*,  genetics,  mortality*,  pathology
Humans
Immunohistochemistry
Lymph Nodes / chemistry*,  pathology
Middle Aged
Multivariate Analysis
Mutation*
Neoplasm Staging
Prognosis
Survival Analysis
Tumor Suppressor Protein p53 / analysis*,  genetics*
Chemical
Reg. No./Substance:
0/Tumor Suppressor Protein p53

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Developmental pattern of NADPH-diaphorase activity in the peripheral nervous system of the cichlid f...
Next Document:  Immunohistochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas.